[Development of farnesyltransferase inhibitor for anti-cancer drugs].
Yasushi
Y
Takemoto
Masaya
M
Imoto
D000818:Animals; D000970:Antineoplastic Agents; D001547:Benzaldehydes / Q000494:pharmacology / Q000627:therapeutic use; D001688:Biological Products; D003512:Cyclohexanones / Q000494:pharmacology / Q000627:therapeutic use; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D051231:Farnesyltranstransferase / Q000037:antagonists & inhibitors* / Q000502:physiology; D018390:Gene Targeting; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D019151:Peptide Library; D021382:Protein Sorting Signals; D018631:ras Proteins; D020743:rhoB GTP-Binding Protein
D000970:Antineoplastic Agents; D001547:Benzaldehydes; D001688:Biological Products; D003512:Cyclohexanones; D004791:Enzyme Inhibitors; D019151:Peptide Library; D021382:Protein Sorting Signals; C508258:moverastin A; D051231:Farnesyltranstransferase; D018631:ras Proteins; D020743:rhoB GTP-Binding Protein